This white paper describes how Signals Research Suite supports a wide range of assay types across pharmaceutical and biotechnology research. As assay diversity increases—spanning biochemical, cellular, in vivo, and omics workflows—traditional data systems struggle to scale. The paper explains how Signals Research Suite provides a flexible, standardized data model that accommodates more than 100 assay modalities while maintaining consistency and traceability. Integrated analytics enable cross-assay comparisons, structure–activity analysis, and decision-ready visualizations. By unifying assay data within a single platform, organizations reduce data silos, improve reproducibility, and accelerate discovery. The paper demonstrates how scalable assay support is essential for modern R&D organizat

Join for free to read